Targeting TGF-β signaling in cancer

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.17, Iss.7, 2013-10, pp. : 743-760

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

TGF-β inhibitors for the treatment of cancer

By Lahn Michael Kloeker Susanne Berry Brandi S

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 6, 2005-06 ,pp. : 629-641

Informa Healthcare

Access to resources Recommend Favorite

From TGF-&bgr; to Cancer Therapy

Current Drug Targets, Vol. 4, Iss. 3, 2003-01 ,pp. : 243-250

Bentham Science Publishers

Access to resources Recommend Favorite

TGF-β: friend or foe? The role of TGF-β/SMAD signaling in epigenetic silencing of ovarian cancer and its implication in epigenetic therapy

By Chou Jian-Liang Chen Lin-Yu Lai Hung-Cheng Chan Michael WY

Expert Opinion on Therapeutic Targets, Vol. 14, Iss. 11, 2010-11 ,pp. : 1213-1223

Informa Healthcare

Access to resources Recommend Favorite

Smad4-Independent TGF-β Signaling in Tumor Cell Migration

Cells Tissues Organs, Vol. 185, Iss. 1-3, 2007-06 ,pp. : 123-130

Karger

Access to resources Recommend Favorite

The TGF-β Signaling Pathway as a Pharmacological Target in a Hepatocellular Carcinoma

Current Pharmaceutical Design, Vol. 18, Iss. 27, 2012-09 ,pp. : 4148-4154

Bentham Science Publishers

Access to resources Recommend Favorite